Family Video Will 'Round It Up For Lymphoma' Again
Family Video, the largest movie and game rental chain in the United States, will hold its 'Round It Up For Lymphoma' fundraiser for the second year in a row.
Beginning March 15 and running through the end of the month, customers of Family Video will be asked if they would be willing to round up their purchase to the nearest dollar. The money rounded up will be donated to one of two causes: the launch of a Lymphoma Tissue Bank at the University of Chicago Medicine and general lymphoma research at the Lymphoma Research Foundation (www.lymphoma.org).
Family Video president Keith Hoogland said in a statement:
Lymphoma is a disease that has touched the lives of many of our employees and their loved ones. By starting this tissue bank, we will be able to better understand why lymphoma develops and study how different environmental factors impact prognosis and treatment.
Ultimately the tissue bank will help us make significant progress toward finding a cure. Our customers have shown their generosity about this cause in the past and we are excited for our company to be able to play this role in the fight against lymphoma.
In 2012, Round It Up For Lymphoma raised $1 million for the Lymphoma Research Foundation, and that is once again the target for Family Video.
More Articles
More Articles
Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...
The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...
Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...
At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...
Site Beginnings
This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...
Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...
The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...
The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...
The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...
According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...
Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...
New research suggests that frontline radioimmunotherapy...
Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...
